Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.
Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. Kavanagh B, et al. Among authors: bercovici n. J Immunother. 2007 Oct;30(7):762-72. doi: 10.1097/CJI.0b013e318133451c. J Immunother. 2007. PMID: 17893568 Clinical Trial.
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
Ribas A, Camacho LH, Lee SM, Hersh EM, Brown CK, Richards JM, Rodriguez MJ, Prieto VG, Glaspy JA, Oseguera DK, Hernandez J, Villanueva A, Chmielowski B, Mitsky P, Bercovici N, Wasserman E, Landais D, Ross MI. Ribas A, et al. Among authors: bercovici n. J Transl Med. 2010 Sep 27;8:89. doi: 10.1186/1479-5876-8-89. J Transl Med. 2010. PMID: 20875102 Free PMC article. Clinical Trial.
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, Leccia MT, Lesimple T, Wijdenes J, Bartholeyns J, Fridman WH, Salcedo M, Ferries E, Tartour E. Bercovici N, et al. J Immunother. 2008 Jan;31(1):101-12. doi: 10.1097/CJI.0b013e318159f5ba. J Immunother. 2008. PMID: 18157017 Clinical Trial.
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M, Bercovici N, Taylor R, Vereecken P, Massicard S, Duriau D, Vernel-Pauillac F, Boyer A, Baron-Bodo V, Mallard E, Bartholeyns J, Goxe B, Latour N, Leroy S, Prigent D, Martiat P, Sales F, Laporte M, Bruyns C, Romet-Lemonne JL, Abastado JP, Lehmann F, Velu T. Salcedo M, et al. Among authors: bercovici n. Cancer Immunol Immunother. 2006 Jul;55(7):819-29. doi: 10.1007/s00262-005-0078-6. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187085 Free PMC article. Clinical Trial.
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA.
Barrou B, Benoît G, Ouldkaci M, Cussenot O, Salcedo M, Agrawal S, Massicard S, Bercovici N, Ericson ML, Thiounn N. Barrou B, et al. Among authors: bercovici n. Cancer Immunol Immunother. 2004 May;53(5):453-60. doi: 10.1007/s00262-003-0451-2. Epub 2004 Feb 4. Cancer Immunol Immunother. 2004. PMID: 14760510 Free PMC article. Clinical Trial.
Multiparameter precursor analysis of T-cell responses to antigen.
Bercovici N, Givan AL, Waugh MG, Fisher JL, Vernel-Pauillac F, Ernstoff MS, Abastado JP, Wallace PK. Bercovici N, et al. J Immunol Methods. 2003 May 1;276(1-2):5-17. doi: 10.1016/s0022-1759(03)00059-0. J Immunol Methods. 2003. PMID: 12738355
New methods for assessing T-cell responses.
Bercovici N, Duffour MT, Agrawal S, Salcedo M, Abastado JP. Bercovici N, et al. Clin Diagn Lab Immunol. 2000 Nov;7(6):859-64. doi: 10.1128/CDLI.7.6.859-864.2000. Clin Diagn Lab Immunol. 2000. PMID: 11063487 Free PMC article. Review. No abstract available.
47 results